In the News

Fox Chase Cancer Center (FCCC) published an article that highlights the work that the Risk Communication Lab and our collaborators at FCCC are doing that brings Fox Chase’s innovative care to the Temple community.

February 27, 2024

The Risk Communication Laboratory received further funding from the National Cancer Institute (NCI) to expand the Gene Pilot tool, which helps educate cancer patients about a test called tumor genomic profiling and articulate common concerns patients have about the procedure.

October 26, 2023

Dr. Sarah Bass was quoted in a Scientific American article covering the new Centers for Disease Control and Prevention (CDC) influenza vaccine information campaign, “From Wild to Mild”.

October 9, 2023

Dr. Bass, our lab director, was featured as a “secret scientist” in a science-themed game show in Philadelphia with the comedy troupe ComedySportz.

October 2, 2023

Dr. Bass, our lab director, was featured on the ReachMD podcast “Clinician’s Roundtable,” where she talked about how the ongoing National Institute on Drug Abuse (NIDA)-funded study aiming to develop and pilot test an app to support women exiting the carceral system access peer support, pre-exposure prophylaxis (PrEP), and medication for opioid use disorder (MOUD), will help reduce the disproportionate burden of HIV among people in the carceral system.

August 8, 2023

Dr. Bass, our lab director, received a $754,000 National Institutes of Health (NIH) grant to create and pilot test an app with our partners at Temple University, University of Pittsburgh, and Philadelphia FIGHT to help women exiting the carceral system access substance use treatment and Pre-Exposure Prophylaxis (PrEP) for HIV.

July 5, 2023